Synthetic DNA manufacturer Twist Bioscience and its top officers were hit with a securities class action on Monday in California Northern District Court. The suit, brought by Kessler Topaz Meltzer & Check, accuses the defendants of overstating the value of the company's DNA chip technology and operating a Ponzi-like scheme to 'create the illusion of growth.' Counsel have not yet appeared for the defendants. The case is 3:22-cv-08168, Peters v. Twist Bioscience Corp. et al.

This suit was surfaced by Law.com Radar, a source for high-speed legal news and litigation updates personalized to your practice. Law.com Radar publishes daily updates on just-filed federal cases like this one. Click here to get started and be first to know about new suits in your region, practice area or client sector.

Read the complaint here: